의료기기 이야기

The aim of this Device Specific Vigilance Guidance (DSVG) is to harmonise vigilance reporting and provide guidance for manufacturers of Specific Devices. It provides further clarification for vigilance reporting of Specific Devices to the relevant Competent Authority and should be read in conjunction with the requirements of Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2..

The European Commission’s Medical Device Coordinating Group (MDCG) has updated its priorities regarding the In Vitro Diagnostic Medical Devices Regulation (IVDR). The MDCG updated its Joint implementation and preparedness plan for the IVDR to reflect ongoing progress of its work and to set new priorities for the European Regulation (EU) 2017/746 (IVDR). IVDR plan organization The 20-page documen..

[Introduction] Article 61(4) of Regulation (EU) 2017/745 on medical devices (MDR) requires clinical investigations to be performed for implantable and class III devices, except in four specific cases as outlined in: CASE 1) indents 1-3 of Article 61(4); CASE 2) Article 61(6)(a); CASE 3) Article 61(6)(b); CASE 4) Article 61(5). These four cases which are exempted from the requirement to perform c..

[Introduction] This document presents questions and answers on requirements related to importers and distributors under Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). The term ‘devices’ will be understood to include medical devices, accessories for medical devices, products listed in Annex XVI of the MDR, in vitro dia..

▶ Introduction The Regulation (EU) 2017/745 on medical devices, hereafter referred to as the MDR (medical device regulation), provides a possibility to use clinical data related to an equivalent device in the clinical evaluation required for a device under conformity assessment. Whilst carrying out a clinical investigation is the most direct way to generate clinical data concerning the safety an..

▶ Introduction The Regulation (EU) 2017/745 on medical devices, hereafter referred to as the MDR, is applicable to the groups of products without an intended medical purpose that are listed in Annex XVI as from the date of application of the Commission Implementing Regulation (EU) 2022/2346, hereinafter referred to as the common specifications (CS). Products without an intended medical purpose t..

유럽연합에서 소프트웨어와 결합할 수 있는 하드웨어 또는 하드웨어 구성요성에 따라 규제사항의 적용 및 조항에 대한 가이던스를 발표하였다 (MDCG 2023-4). [소프트웨어 (MDSW)와 결합 가능한 하드웨어 조건 리스트] 1. A회사에서 생체신호를 획득하는 HW 또는 HW components를 만들고, 이와 연동이 되는 SW도 제작하는 경우 2. A회사에서 생체신호를 획득하는 HW 또는 HW components를 만들고, B회사에서 HW 또는 HW components와 연동이 되는 SW를 제작하는 경우 3. A회사에서 스마트폰 또는 웨어러블 디바이스를 통한 생체신호를 측정하여 SW에 전달되는 경우 4. A회사에서 스마트폰 또는 웨어러블 디바이스에서 측정된 생체신호를, B회사의 SW (App)에 전달되는..

The RAPS Convergence 2023 concluded on 5 October 2023. For a few glorious days, professionals convened in Montreal, Canada to discuss all aspects regulatory. One topic discussed extensively covered notified bodies and the European Medical Devices Regulation (2017/745, MDR). Notified bodies have been working to harmonize their activities. Notified body representatives have attended meetings and a..

▶ MDCG 2020-3 문서가 'Regulation 2023/607'과 'MDCG 2022-2' 문서에 맞게 전체적으로 개정 되었음 ▶ Significant change - intended purpose - design - software - substance or materials - sterilization